Cost-effectiveness of hospital pay-for-performance incentives

Med Care Res Rev. 2006 Feb;63(1 Suppl):49S-72S. doi: 10.1177/1077558705283629.

Abstract

One increasingly popular mechanism for stimulating quality improvements is pay-for-performance, or incentive, programs. This article examines the cost-effectiveness of a hospital incentive system for heart-related care, using a principal-agent model, where the insurer is the principal and hospitals are the agents. Four-year incentive system costsfor the payer were dollar 22,059,383, composed primarily of payments to the participating hospitals, with approximately 5 percent in administrative costs. Effectiveness is measured in stages, beginning with improvements in the processes of heart care. Care process improvements are converted into quality-adjusted life years (QALYs) gained, with reference to literatures on clinical effectiveness and survival. An estimated 24,418 patients received improved care, resulting in a range of QALYs from 733 to 1,701, depending on assumptions about clinical effectiveness. Cost per QALY was found to be between dollar 12,967 and dollar 30,081, a level well under consensus measures of the value of a QALY.

Publication types

  • Evaluation Study

MeSH terms

  • Blue Cross Blue Shield Insurance Plans / economics*
  • Cardiology Service, Hospital / economics
  • Cardiology Service, Hospital / standards*
  • Cost-Benefit Analysis
  • Employee Incentive Plans
  • Health Services Research
  • Heart Diseases / drug therapy
  • Heart Diseases / economics
  • Heart Diseases / mortality
  • Heart Diseases / therapy*
  • Hospital Costs
  • Humans
  • Michigan / epidemiology
  • Organizational Case Studies
  • Patient Discharge / standards
  • Process Assessment, Health Care
  • Program Evaluation
  • Quality Assurance, Health Care / economics*
  • Quality Assurance, Health Care / methods
  • Quality-Adjusted Life Years*
  • Reimbursement, Incentive*
  • Survival Rate